Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
TCMD | US
-0.52
-2.12%
Healthcare
Medical Devices
30/06/2024
07/04/2026
24.05
24.61
24.63
23.96
Tactile Systems Technology Inc. a medical technology company develops and provides medical devices for the treatment of underserved chronic diseases in the United States. It offers Flexitouch Plus system a pneumatic compression device for the treatment of lymphedema; Entre System a portable pneumatic compression device for the at-home treatment of venous disorders such as lymphedema and chronic venous insufficiency including venous leg ulcers; Kylee a mobile application to help patients learn about lymphedema track their symptoms treatment and share their progress with their doctor; and AffloVest a portable high frequency chest wall oscillation vest for the treatment of retained pulmonary secretions such as bronchiectasis cystic fibrosis and various neuromuscular disorders. The company was incorporated in 1995 and is headquartered in Minneapolis Minnesota.
View LessLow Debt to Equity (< 0.25)
Low Debt to Asset (< 0.2)
Value Stock (Price to Book < 3)
Negative Momentum (Declining Price)
Price Below SMA10D
High 6-Month Volatility (>65%)
Smallcap (300M - 2B USD)
High Market Beta (> 0.8)
Weak Operating Margin (< 10%)
Bearish: Increased Volatility (6-month > 1-month volatility)
10 days
30.2%1 month
28.0%3 months
55.0%6 months
76.1%10.39
19.27
1.75
0.24
0.17
10.65
1.11
17.24
25.58M
576.40M
576.40M
-
7.99
54.80
7.10
18.13
9.23
5.56
Short-term: Bearish (SMA10D < SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bullish (SMA6M > SMA12M)
Range10D
3.80
Range1M
5.10
Range3M
13.81
Rel. volume
0.98
Price X volume
6.27M
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
|---|---|---|---|---|---|---|---|
| Cytek Biosciences Inc. Common Stock | CTKB | Medical Devices | 4.6 | 604.93M | 1.77% | n/a | 8.53% |
| Bioventus Inc. | BVS | Medical Devices | 8.84 | 576.25M | -2.00% | n/a | 261.56% |
| MiMedx Group Inc | MDXG | Medical Devices | 3.86 | 566.68M | -0.52% | 10.21 | 11.46% |
| SI-BONE Inc | SIBN | Medical Devices | 13.17 | 549.11M | -0.30% | n/a | 24.28% |
| Embecta Corp | EMBC | Medical Instruments & Supplies | 8.83 | 509.51M | -1.12% | 11.37 | -216.41% |
| Orthofix International N.V | OFIX | Medical Devices | 11.71 | 447.03M | -0.51% | n/a | 28.63% |
| Neuropace Inc. Common Stock | NPCE | Medical Devices | 14.51 | 423.65M | -0.62% | n/a | 745.17% |
| AngioDynamics Inc | ANGO | Medical Instruments & Supplies | 9.7 | 394.15M | -1.42% | n/a | 2.44% |
| OrthoPediatrics Corp | KIDS | Medical Devices | 15.76 | 381.62M | -1.13% | n/a | 3.67% |
| Common Stock | VMD | Medical Devices | 9.61 | 373.12M | -1.54% | 39.96 | 10.44% |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
|---|---|---|---|---|---|---|---|
| Latham Group Inc. | SWIM | Building Products & Equipment | 5.17 | 597.53M | -2.08% | 65.18 | 77.00% |
| Ennis Inc | EBF | Building Products & Equipment | 21.72 | 564.80M | -0.23% | 13.28 | 2.28% |
| The Real Brokerage Inc. Common Shares | REAX | Real Estate Services | 2.45 | 484.50M | -3.16% | n/a | 0.00% |
| FRP Holdings Inc | FRPH | Real Estate Services | 22.13 | 421.14M | -0.23% | 75.50 | 42.65% |
| ACCO Brands Corporation | ACCO | Building Products & Equipment | 2.84 | 272.07M | -1.73% | n/a | 174.23% |
| The RMR Group Inc | RMR | Real Estate Services | 15.81 | 264.42M | -0.50% | 16.64 | 14.14% |
| Comstock Holding Companies Inc | CHCI | Real Estate Services | 18.85 | 185.90M | -2.43% | 14.10 | 17.12% |
| CPI Card Group Inc | PMTS | Building Products & Equipment | 16.33 | 182.21M | -1.27% | 15.61 | -621.78% |
| RE/MAX Holdings Inc | RMAX | Real Estate Services | 5.74 | 180.33M | -1.20% | n/a | 114.28% |
| Douglas Elliman Inc. | DOUG | Real Estate Services | 1.6 | 146.93M | -4.19% | n/a | 62.82% |
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | 10.65 | 46.09 | Cheaper |
| Ent. to Revenue | 1.11 | 14.34 | Cheaper |
| PE Ratio | 10.39 | 30.41 | Cheaper |
| Price to Book | 1.75 | 6.21 | Cheaper |
| Dividend Yield | - | 1.78 | - |
| Std. Deviation (3M) | 55.01 | 64.12 | Par |
| Debt to Equity | 0.24 | -145.53 | Expensive |
| Debt to Assets | 0.17 | 0.35 | Cheaper |
| Market Cap | 576.40M | 9.70B | Emerging |